Adverse effect of smoking on prognosis in human papillomavirus–associated oropharyngeal carcinoma
- 1 June 2016
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 38 (12), 1780-1787
- https://doi.org/10.1002/hed.24516
Abstract
Background The purpose of this retrospective study was to identify prognostic factors in a cohort of patients with oropharyngeal carcinoma treated with intensity‐modulated radiotherapy (IMRT). Methods Medical records of 142 patients treated with (chemo)radiotherapy between September 2005 and September 2011 were reviewed and the human papillomavirus (HPV) status was determined by polymerase chain reaction (PCR) analysis. Potential prognostic factors for 3‐year locoregional control and overall survival (OS) were evaluated. Results HPV‐positive patients (n = 82) had locoregional control and OS of 78% and 79%, respectively. Significant prognostic factors on multivariate analysis were smoking (p = .03) for locoregional control and OS, and comorbidity (p = .04) for OS. Further stratification was done according to smoking behavior in HPV‐positive patients. Locoregional control in current smokers was 67% compared to 86% in never smokers and former smokers, respectively (p = .02). Conclusion Smoking was the only modifiable prognostic factor in HPV‐positive patients. Therefore, active stop‐smoking programs must be integrated in the routine management of patients to maximize treatment results. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1780–1787, 2016Keywords
This publication has 41 references indexed in Scilit:
- Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992–2009Cancer Causes & Control, 2012
- The Mutational Landscape of Head and Neck Squamous Cell CarcinomaScience, 2011
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour siteRadiotherapy and Oncology, 2011
- Oropharyngeal cancer: clinical implications of the HPV connectionAnnals Of Oncology, 2011
- Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialJournal of Clinical Oncology, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor RecurrenceClinical Cancer Research, 2010
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomasThe Laryngoscope, 2009
- Gene expression profiles in HPV-immortalized human cervical cells treated with the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanoneChemico-Biological Interactions, 2009